Endometriosis was once thought to affect only reproductive-aged women. However, 2-5% of postmenopausal individuals remain affected. Guidance for this group is limited. This review outlines an updated approach to postmenopausal …
Tell Me About Oestra for Menopause Hormone Therapy? Dr. Jen Gunter | Substack
Medroxyprogesterone Acetate Market Forecast 2026-2035: Growth Driven by Contraceptive Access and Hormone Therapy - News and Statistics IndexBox
Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet sex-specific risk factors are usually not included in conventional predictive models. Specifically, heart failure (HF) in women may …
Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen …
Menopause: Hormone therapy linked to 69% lower risk of thinning bones Medical News Today
To challenge the perception that endometriosis uniformly regresses after menopause by presenting the case of repeated, pathology-confirmed symptomatic recurrences spanning two decades after menopause, and to emphasize key considerations for …
Women ‘blindsided’ as critical hormone therapy pulled from shelves Herald Sun
Women ‘blindsided’ as critical hormone therapy pulled from shelves NT News
Women ‘blindsided’ as critical hormone therapy pulled from shelves The Cairns Post